Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Shukra Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524632NSE Symbol: Not ListedP/E(TTM):27.42
ISIN Demat:INE551C01028Div & Yield %:0.04EPS(TTM):4.23
Book Value(Rs):10.1085326Market Cap ( Cr.):507.81Face Value(Rs):10
    Change Company 
Date Headline
25-Apr-24 Board of Shukra Pharmaceuticals allots 3.28 cr bonus shares
18-Mar-24 Shukra Pharmaceuticals schedules board meeting
24-Feb-24 Shukra Pharmaceuticals to conduct board meeting
05-Feb-24 Shukra Pharmaceuticals to discuss results
03-Feb-24 Shukra Pharmaceuticals Ltd - Board Meeting Intimation for For Considering And Approving The Unaudited Financial Result F..
03-Jan-24 Shukra Pharmaceuticals Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
30-Dec-23 Shukra Pharmaceuticals Ltd - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
30-Dec-23 Shukra Pharmaceuticals Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
30-Dec-23 Shukra Pharmaceuticals Ltd - Closure of Trading Window
22-Dec-23 Shukra Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
<< < 1 2 3 4 > >>